Literature DB >> 10391916

Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity.

H Segawa1, Y Fukasawa, K Miyamoto, E Takeda, H Endou, Y Kanai.   

Abstract

We have isolated a cDNA from rat small intestine that encodes a novel Na+-independent neutral amino acid transporter with distinctive characteristics in substrate selectivity and transport property. The encoded protein, designated L-type amino acid transporter-2 (LAT-2), shows amino acid sequence similarity to the system L Na+-independent neutral amino acid transporter LAT-1 (Kanai, Y., Segawa, H., Miyamoto, K., Uchino, H., Takeda, E., and Endou, H. (1998) J. Biol. Chem. 273, 23629-23632) (50% identity) and the system y+L transporters y+LAT-1 (47%) and KIAA0245/y+LAT-2 (45%) (Torrents, D., Estevez, R., Pineda, M., Fernandez, E., Lloberas, J., Shi, Y.-B., Zorzano, A., and Palacin, M. (1998) J. Biol. Chem. 273, 32437-32445). LAT-2 is a nonglycosylated membrane protein. It requires 4F2 heavy chain, a type II membrane glycoprotein, for its functional expression in Xenopus oocytes. LAT-2-mediated transport is not dependent on Na+ or Cl- and is inhibited by a system L-specific inhibitor, 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH), indicating that LAT-2 is a second isoform of the system L transporter. Compared with LAT-1, which prefers large neutral amino acids with branched or aromatic side chains, LAT-2 exhibits remarkably broad substrate selectivity. It transports all of the L-isomers of neutral alpha-amino acids. LAT-2 exhibits higher affinity (Km = 30-50 microM) to Tyr, Phe, Trp, Thr, Asn, Ile, Cys, Ser, Leu, Val, and Gln and relatively lower affinity (Km = 180-300 microM) to His, Ala, Met, and Gly. In addition, LAT-2 mediates facilitated diffusion of substrate amino acids, as distinct from LAT-1, which mediates amino acid exchange. LAT-2-mediated transport is increased by lowering the pH level, with peak activity at pH 6.25, because of the decrease in the Km value without changing the Vmax value. Because of these functional properties and a high level of expression of LAT-2 in the small intestine, kidney, placenta, and brain, it is suggested that the heterodimeric complex of LAT-2 and 4F2 heavy chain is involved in the trans-cellular transport of neutral amino acids in epithelia and blood-tissue barriers.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391916     DOI: 10.1074/jbc.274.28.19745

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  126 in total

Review 1.  Role of plasma membrane transporters in muscle metabolism.

Authors:  A Zorzano; C Fandos; M Palacín
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

2.  Activation of system L heterodimeric amino acid exchangers by intracellular substrates.

Authors:  Christian Meier; Zorica Ristic; Stefan Klauser; François Verrey
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

3.  The light subunit of system b(o,+) is fully functional in the absence of the heavy subunit.

Authors:  Núria Reig; Josep Chillarón; Paola Bartoccioni; Esperanza Fernández; Annie Bendahan; Antonio Zorzano; Baruch Kanner; Manuel Palacín; Joan Bertran
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

4.  Distribution of cystine/glutamate exchange transporter, system x(c)-, in the mouse brain.

Authors:  Hideyo Sato; Michiko Tamba; Suzuka Okuno; Kanako Sato; Kazuko Keino-Masu; Masayuki Masu; Shiro Bannai
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

5.  Regulation of system x(c)(-)activity and expression in astrocytes by interleukin-1β: implications for hypoxic neuronal injury.

Authors:  Nicole A Jackman; Tracy F Uliasz; James A Hewett; Sandra J Hewett
Journal:  Glia       Date:  2010-11-15       Impact factor: 7.452

Review 6.  Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems.

Authors:  Akira Tsuji
Journal:  NeuroRx       Date:  2005-01

Review 7.  Molecular imaging of brain tumors: a bridge between clinical and molecular medicine?

Authors:  B J Schaller; M Modo; M Buchfelder
Journal:  Mol Imaging Biol       Date:  2007 Mar-Apr       Impact factor: 3.488

8.  Bidirectional transport of amino acids regulates mTOR and autophagy.

Authors:  Paul Nicklin; Philip Bergman; Bailin Zhang; Ellen Triantafellow; Henry Wang; Beat Nyfeler; Haidi Yang; Marc Hild; Charles Kung; Christopher Wilson; Vic E Myer; Jeffrey P MacKeigan; Jeffrey A Porter; Y Karen Wang; Lewis C Cantley; Peter M Finan; Leon O Murphy
Journal:  Cell       Date:  2009-02-06       Impact factor: 41.582

9.  LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates.

Authors:  Arik A Zur; Huan-Chieh Chien; Evan Augustyn; Andrew Flint; Nathan Heeren; Karissa Finke; Christopher Hernandez; Logan Hansen; Sydney Miller; Lawrence Lin; Kathleen M Giacomini; Claire Colas; Avner Schlessinger; Allen A Thomas
Journal:  Bioorg Med Chem Lett       Date:  2016-09-03       Impact factor: 2.823

10.  Amino acid transporter LAT3 is required for podocyte development and function.

Authors:  Yuji Sekine; Yukino Nishibori; Yoshihiro Akimoto; Akihiko Kudo; Noriko Ito; Daisuke Fukuhara; Ryota Kurayama; Eiji Higashihara; Ellappan Babu; Yoshikatsu Kanai; Katsuhiko Asanuma; Michio Nagata; Arindam Majumdar; Karl Tryggvason; Kunimasa Yan
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.